Screener
Regeneron Pharmaceuticals REGN Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's invested capital?
- Regeneron Pharmaceuticals (REGN) reported invested capital of $31.95B in Q2 2026.
- How has Regeneron Pharmaceuticals's invested capital changed year-over-year?
- Regeneron Pharmaceuticals's invested capital increased by 4.3% year-over-year, from $30.63B to $31.95B.
- What is the long-term trend for Regeneron Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's invested capital has grown at a 22.0% compound annual growth rate (CAGR), from $11.51B to $31.11B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Regeneron Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude